Van Oene Mark's Form 4 filing
Pacific Biosciences of California, Inc. (PACB) · filed Feb 19, 2026
- Accession no.
- 0001299130-26-000023
- Filed
- Feb 19, 2026
- Trade date
- Feb 17-18, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $294.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Van Oene MarkCIK 0001707477 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | SSaleDisposed | −129,790 | $1.58 | −$205,068.2 | 1,797,745 | Direct | |
| Feb 18, 2026 | Common Stock | SSaleDisposed | −55,107 | $1.63 | −$89,824.41 | 1,742,638 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.